FierceBiotech Feb 13, 2026 FDA clears Encora Therapeutics’ wearable wrist device for essential tremor
FierceBiotech Feb 13, 2026 After R&D head exits, Immunocore CEO pairs ambition with caution for growing cancer portfolio
FierceBiotech Feb 13, 2026 Integra LifeSciences cuts roles as 65 staffers impacted from Princeton, N.J., site
FierceBiotech Feb 13, 2026 Ultragenyx lays off 10% of workforce as FDA continues to stall gene therapy approval plans
FierceBiotech Feb 13, 2026 'When the markets opened, we were ready': Why biotech IPOs are back for 2026
FierceBiotech Feb 12, 2026 Icon shares plummet after CRO reveals accounting investigation, pulls 2025 guidance
FierceBiotech Feb 12, 2026 Lundbeck’s migraine prevention treatment sees ph. 2 success after trial’s earlier setback
FierceBiotech Feb 12, 2026 BridgeBio preps approval push after dwarfism drug increases children's height in phase 3
FierceBiotech Feb 12, 2026 Langer-backed biotech looks to end cancer recurrence with surgical revolution
FierceBiotech Feb 12, 2026 Agilent companion diagnostic lands FDA nod alongside Keytruda's latest cancer approval
FierceBiotech Feb 12, 2026 Seres to lay off 30% of employees, pause lead program in latest strategic shift
FierceBiotech Feb 12, 2026 Sanofi ousts Paul Hudson after ‘bumpy ride’, poaches Merck KGaA CEO to lead the French pharma
FierceBiotech Feb 12, 2026 European VCs join forces to boost flagging biotech investment in the region
FierceBiotech Feb 12, 2026 UPDATE: After Moderna's rebuke, HHS stands behind FDA decision to spurn mRNA flu filing